A recent study has shown that using injectable Mistletoe (an herbal extract) increases survival time in cancer treatment by over 40%. (1) The study followed thousands of matched pairs of patients with lung, colon, rectum, stomach and breast carcinoma with or without metastasis. Not only did survival time in the mistletoe treated patients far exceed the survival time of the mistletoe non treated patients but also the sense of well being and the so called ability for self regulation increased dramatically. Self regulation was shown to be a predictor for better prognosis in the success of cancer treatment.

In the present study the mistletoe preparation used was Iscador but similar results are seen with other mistletoes preparations – Helixor, etc. Taken together the various mistletoe preparations are the most commonly prescribed cancer “drugs” in Central Europe – given as part of a complementary medicine program. They have been safely prescribed for many decades.

Mistletoe preparations are:

• stimulating the immune system
• prolong the survival time in cancer treatment
• directly cause cancer cell death without harming healthy cells
• increase the sense of well being of patients and help to tolerate any conventionally given chemotherapy or radiation (if the need for such therapy arises)

They are essentially side effects free.

Dr. Ross Rentea has also published studies on the mistletoe extract Iscador at the University of Chicago already in 1976. 

We have prescribed mistletoe preparations as injections, intravenous infusions and also by oral application for over 35 years with great success. Many patients who came to us having been given only months to live are still with us many years later. Of course individual situations and destinies differ but considering the positive world wide experience a try is very much worthwhile.

Find out more information on our Cancer page.

Also see the mistletoe study at the Johns Hopkins University Kimmel Center

https://www.hopkinsmedicine.org/kimmel_cancer_center/research_clinical_trials/clinical_trials/mistletoe.html

(1)

Use of Iscador , an extract of European mistletoe (Viscum Album), in Cancer Treatment: Prospective nonrandomized and randomized matched–pair studies nested within a cohort study, R. Grossarth-Maticek, et al, Alternative Therapies, May/June 2001, Vol. 7, No.3